Cytokeratin 19 Antibody

About the Target

CK19 is a target of interest in many antibody-based workflows. Cytokeratins (CKs or keratins) are a group of intermediate filament proteins found in epithelial cells. They are classified into type I (CK9-20) and type II (CK1-8) proteins based on conventional classification. Cytokeratin 19 (KRT19) is the smallest member (40 kDa) of the acidic type I cytokeratin family proteins (KRTs) and detects tumors using reverse transcriptase polymerase chain reaction (RT-PCR) in the bone marrow, lymph nodes, and peripheral blood of breast cancer patients. Depending on the literature source, CK19 may also be discussed as Cytokeratin 19 and Cytokeratin Peptide 19.

Reported cellular context includes intermediate filament and keratin, which can matter when signal is compared across treatments or changing cell states. Following CK19 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

CK19 is commonly interpreted in the context of cancer, stem cell biology, and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans intermediate filament and keratin, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• apparent redistribution between intermediate filament and keratin across matched conditions
• changes associated with proliferative state, oncogenic signaling, or treatment response
• state transitions between self-renewal, priming, and differentiation
• signal-dependent shifts after ligand, inhibitor, or growth-factor perturbation

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for CK19. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in CK19 reflect biology rather than handling. When interpreting CK19, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep CK19 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.